Literature DB >> 176929

Inhibition of Clostridium perfringens by an antibiotic substance produced by Bacillus licheniformis in the digestive tract of gnotobiotic mice: effect on other bacteria from the digestive tract.

R Ducluzeau, F Dubos, P Raibaud, G D Abrams.   

Abstract

A strain of Bacillus licheniformis, established in the digestive tract of gnotobiotic mice, inhibited the subsequent establishment of a Clostridium perfringens strain ingested by the animals. This inhibitory effect depended on the in vivo production by B. licheniformis of an antibiotic substance having a number of the characteristics of bacitracin. If C. perfringens was the first to become established in the digestive tract of the gnotobiotic mice, B. licheniformis also became established but did not produce any antibiotic. Mutants of C. perfringens resistant to the antibiotic substance were not observed when the antibiotic was produced in situ by B. licheniformis, but were rapidly selected when the Bacillus culture filtrate or bacitracin was administered per os. B. licheniformis was also capable of eliminating from the digestive tract 5 of the 13 additional bacterial strains tested.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 176929      PMCID: PMC429468          DOI: 10.1128/AAC.9.1.20

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  BACITRACIN BIOSYNTHESIS AND SPORE FORMATION: THE PHYSIOLOGICAL ROLE OF AN ANTIBIOTIC.

Authors:  R W BERNLOHR; G D NOVELLI
Journal:  Arch Biochem Biophys       Date:  1963-10       Impact factor: 4.013

2.  Bacitracin: Methods of Production, Concentration, and Partial Purification, with a Summary of the Chemical Properties of Crude Bacitracin.

Authors:  H S Anker; B A Johnson; J Goldberg; F L Meleney
Journal:  J Bacteriol       Date:  1948-02       Impact factor: 3.490

3.  [Effect of the ingestion of varied amounts of antibiotics on the microflora of gnotoxenic mice].

Authors:  R Ducluzeau; M Bellier; P Raibaud
Journal:  Ann Inst Pasteur (Paris)       Date:  1971-08

4.  Diet and the equilibrium between bacteria and yeast implanted in gnotobiotic rats.

Authors:  P Raibaud; R Ducluzeau; M C Muller; G D Abrams
Journal:  Am J Clin Nutr       Date:  1972-12       Impact factor: 7.045

5.  [Implantation of a lysogenic strain and a sensitive strain of Escherichia coli K 12 in the digestive tube of axenic mice: establishment of a balance].

Authors:  R Ducluzeau; J C Salomon; J Huppert
Journal:  Ann Inst Pasteur (Paris)       Date:  1967-02

6.  [Microflora of the digestive system of the rat. I. Technics of study and proposed culture media].

Authors:  P Raibaud; A B Dickinson; E Sacquet; H Charlier; G Mocquot
Journal:  Ann Inst Pasteur (Paris)       Date:  1966-04

7.  [Comparative study of the microbial flora of the stomach, small intestine and cecum in "holoxenic" (conventional) rats and its changes after various surgical interventions: blind jejunal loops or bile duct fistulae].

Authors:  E Sacquet; P Raibaud; J Garnier
Journal:  Ann Inst Pasteur (Paris)       Date:  1971-04

8.  [Transit through the digestive tract of the inocula of several bacterial strains introduced "per Os" into axenic and "Holoxenic" mice. The antagonistic effect of the microflora of the gastrointestinal tract].

Authors:  R Ducluzeau; M Bellier; P Raibaud
Journal:  Zentralbl Bakteriol Orig       Date:  1970-05
  8 in total
  9 in total

1.  Antagonisms among isogenic strains of Escherichia coli in the digestive tracts of gnotobiotic mice.

Authors:  Y Duval-Iflah; P Raibaud; M Rousseau
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

Review 2.  Microbiota-mediated colonization resistance against intestinal pathogens.

Authors:  Charlie G Buffie; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2013-10-07       Impact factor: 53.106

3.  Production of an antibiotic substance by Bacillus licheniformis within the digestive tract of gnotobiotic mice.

Authors:  R Ducluzeau; F Dubos; P Raibaud; G D Abrams
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

4.  Trypsin-dependent production of an antibacterial substance by a human Peptostreptococcus strain in gnotobiotic rats and in vitro.

Authors:  F Ramare; J Nicoli; J Dabard; T Corring; M Ladire; A M Gueugneau; P Raibaud
Journal:  Appl Environ Microbiol       Date:  1993-09       Impact factor: 4.792

5.  Antagonistic effect of extremely oxygen-sensitive clostridia from the microflora of conventional mice and of Escherichia coli against Shigella flexneri in the digestive tract of gnotobiotic mice.

Authors:  R Ducluzeau; M Ladire; C Callut; P Raibaud; G D Abrams
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

6.  Characterization of Lactobacillus sp. strain 100-37 from the murine gastrointestinal tract: ecology, plasmid content, and antagonistic activity toward Clostridium ramosum H1.

Authors:  E L McCormick; D C Savage
Journal:  Appl Environ Microbiol       Date:  1983-11       Impact factor: 4.792

Review 7.  The multifaceted role of commensal microbiota in homeostasis and gastrointestinal diseases.

Authors:  Marcelo José Barbosa Silva; Matheus Batista Heitor Carneiro; Brunna dos Anjos Pultz; Danielle Pereira Silva; Mateus Eustáquio de Moura Lopes; Liliane Martins dos Santos
Journal:  J Immunol Res       Date:  2015-02-22       Impact factor: 4.818

8.  Identification and classification of known and putative antimicrobial compounds produced by a wide variety of Bacillales species.

Authors:  Xin Zhao; Oscar P Kuipers
Journal:  BMC Genomics       Date:  2016-11-07       Impact factor: 3.969

9.  Disruption in the cecal microbiota of chickens challenged with Clostridium perfringens and other factors was alleviated by Bacillus licheniformis supplementation.

Authors:  Yicen Lin; Shuai Xu; Dong Zeng; Xueqin Ni; Mengjia Zhou; Yan Zeng; Hesong Wang; Yi Zhou; Hui Zhu; Kangcheng Pan; Guangyao Li
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.